{
    "clinical_study": {
        "@rank": "45371", 
        "brief_summary": {
            "textblock": "The study objective is to confirm that the MBT-CA System identifies medically significant\n      bacteria and yeasts from an isolated colony from any sample type processed by the clinical\n      laboratory. For this purpose MBT-CA test results will be compared to bi-directional\n      sequencing results."
        }, 
        "brief_title": "Evaluation of MALDI Biotyper CA System for Detection of Gram- and Gram+ Bacteria and Yeasts", 
        "condition": "Infection", 
        "detailed_description": {
            "textblock": "Bacteria or yeast isolates (1) fresh from primary culture plates, (2) collected directly\n      from clinical samples, stored in the refrigerator or frozen or (3) well characterized\n      organisms from a variety of contemporary culture collections will be included in the study.\n      All organisms to be included in the study will be cultured on an agar medium prior to\n      measurement.\n\n      Testing will be performed for various Gram negative and Gram positive bacteria and yeasts as\n      outlined below. Several thousands of samples will be measured via MBT-CA systems based on\n      MALDI-TOF MS technology (matrix assisted laser desorption ionisation time-of-flight mass\n      spectrometry) at the test sites as fresh or frozen isolates of bacteria and yeasts. Lower\n      prevalence organisms may be supplemented from banked culture collections.\n\n      The MBT-CA system uses an organism identification based on unique protein patterns of the\n      microorganisms obtained from mass spectrometry. The test organism's spectrum (a pattern of\n      mass peaks) is compared with a reference spectra library (database). Using biostatistical\n      analysis, a probability ranking of the organism identification is generated. The probability\n      ranking is represented as a log(score) between 0.00 and 3.00. Organism identification is\n      reported with high confidence if the log(score) is \u2265 2.00.  An organism identification is\n      reported with low confidence if the log(score) is between 1.70 and <2.00.\n\n      In the last step the samples are sent to a special site for sequencing. Finally, the\n      respective sequencing results are compared with the MBT-CA results.\n\n      Target microorganisms of study:\n\n        1. GN Acinetobacter haemolyticus\n\n        2. GN Acinetobacter johnsonii\n\n        3. GN Acinetobacter junii\n\n        4. AA Actinomyces hyovaginalis\n\n        5. AA Actinomyces meyeri\n\n        6. AA Actinomyces neuii\n\n        7. AA Actinomyces odontolyticus\n\n        8. AA Actinomyces oris\n\n        9. GP Aerococcus urinae\n\n       10. GP Aerococcus viridans\n\n       11. GN Aeromonas salmonicida\n\n       12. GP Alloiococcus otitis\n\n       13. AA Anaerococcus murdochii\n\n       14. AA Anaerococcus vaginalis\n\n       15. AA Bacteroides fragilis\n\n       16. AA Bacteroides ovatus\n\n       17. AA Bacteroides thetaiotaomicron\n\n       18. AA Bacteroides uniformis\n\n       19. AA Bacteroides vulgatus\n\n       20. GN Bordetella bronchiseptica\n\n       21. GN Bordetella hinzii\n\n       22. GN Bordetella parapertussis\n\n       23. GN Bordetella pertussis\n\n       24. GN Bordetella petrii\n\n       25. GP Brevibacterium casei\n\n       26. GN Brevundimonas diminuta\n\n       27. MA Campylobacter coli\n\n       28. MA Campylobacter curvus\n\n       29. MA Campylobacter gracilis\n\n       30. MA Campylobacter jejuni\n\n       31. MA Campylobacter ureolyticus\n\n       32. YE Candida albicans\n\n       33. YE Candida boidinii\n\n       34. YE Candida dubliniensis\n\n       35. YE Candida duobushaemulonii\n\n       36. YE Candida glabrata\n\n       37. YE Candida haemulonii\n\n       38. YE Candida inconspicua\n\n       39. YE Candida metapsilosis\n\n       40. YE Candida orthopsilosis\n\n       41. YE Candida parapsilosis\n\n       42. YE Candida pararugosa\n\n       43. YE Candida tropicalis\n\n       44. YE Candida_guilliermondii[ana] (Pichia_guilliermondii[teleo])\n\n       45. YE Candida_guilliermondii_var_membranaefaciens[ana] (Pichia_ohmeri[teleo])\n\n       46. YE Candida_kefyr[ana] (Kluyveromyces_marxianus_ssp_marxianus[teleo])\n\n       47. YE Candida_krusei[ana] (Issatchenkia_orientalis[teleo])\n\n       48. YE Candida_lambica[ana] (Pichia_fermentans[teleo])\n\n       49. YE Candida_lipolytica[ana] (Yarrowia_lipolytica[teleo])\n\n       50. YE Candida_lusitaniae[ana] (Clavispora_lusitaniae[teleo])\n\n       51. YE Candida_norvegensis[ana] (Pichia_norvegensis[teleo])\n\n       52. YE Candida_pelliculosa[ana] (Pichia_anomala[teleo])\n\n       53. YE Candida_robusta[ana] (Saccharomyces_cerevisiae[teleo])\n\n       54. YE Candida_valida[ana] (Pichia_membranifaciens[teleo])\n\n       55. GN Capnocytophaga ochracea\n\n       56. GN Capnocytophaga sputigena\n\n       57. GN Chryseobacterium gleum\n\n       58. GN Chryseobacterium indologenes\n\n       59. AA Clostridium difficile\n\n       60. AA Clostridium perfringens\n\n       61. GP Corynebacterium amycolatum\n\n       62. GP Corynebacterium aurimucosum\n\n       63. GP Corynebacterium bovis\n\n       64. GP Corynebacterium diphtheriae\n\n       65. GP Corynebacterium glucuronolyticum\n\n       66. GP Corynebacterium glutamicum\n\n       67. GP Corynebacterium jeikeium\n\n       68. GP Corynebacterium kroppenstedtii\n\n       69. GP Corynebacterium macginleyi\n\n       70. GP Corynebacterium minutissimum\n\n       71. GP Corynebacterium propinquum\n\n       72. GP Corynebacterium pseudodiphtheriticum\n\n       73. GP Corynebacterium pseudotuberculosis\n\n       74. GP Corynebacterium riegelii\n\n       75. GP Corynebacterium striatum\n\n       76. GP Corynebacterium tuberculostearicum\n\n       77. GP Corynebacterium ulcerans\n\n       78. GP Corynebacterium urealyticum\n\n       79. GP Corynebacterium xerosis\n\n       80. GN Cronobacter sakazakii\n\n       81. YE Cryptococcus neoformans_var_grubii\n\n       82. YE Cryptococcus neoformans_var_neoformans\n\n       83. YE Cryptococcus_gattii[ana] (Filobasidiella_bacillispora[teleo])\n\n       84. GN Cupriavidus pauculus\n\n       85. YE Debaryomyces hansenii\n\n       86. GN Delftia acidovorans\n\n       87. GP Dermacoccus nishinomiyaensis\n\n       88. GN Edwardsiella tarda\n\n       89. GN Elizabethkingia meningoseptica\n\n       90. GN Enterobacter amnigenus\n\n       91. GP Enterococcus avium\n\n       92. GP Enterococcus casseliflavus\n\n       93. GP Enterococcus faecalis\n\n       94. GP Enterococcus faecium\n\n       95. GP Enterococcus gallinarum\n\n       96. GP Enterococcus hirae\n\n       97. AA Finegoldia magna\n\n       98. AA Fusobacterium canifelinum\n\n       99. AA Fusobacterium necrophorum\n\n      100. AA Fusobacterium nucleatum\n\n      101. GP Gardnerella vaginalis\n\n      102. GP Gemella haemolysans\n\n      103. GP Gemella sanguinis\n\n      104. YE Geotrichum_candidum[ana] (Galactomyces_geotrichum[teleo])\n\n      105. YE Geotrichum_capitatum[ana] (Magnusiomyces_capitatus[teleo]#)\n\n      106. GP Granulicatella adiacens\n\n      107. GN Haemophilus haemolyticus\n\n      108. GN Haemophilus parahaemolyticus\n\n      109. GN Kingella kingae\n\n      110. YE Kloeckera_apiculata[ana] (Hanseniaspora_uvarum[teleo])\n\n      111. GP Kocuria kristinae\n\n      112. GP Kytococcus sedentarius\n\n      113. GP Lactococcus garvieae\n\n      114. GP Lactococcus lactis\n\n      115. GP Leuconostoc mesenteroides\n\n      116. GP Macrococcus caseolyticus\n\n      117. GP Micrococcus luteus\n\n      118. GN Moraxella_sg_Moraxella nonliquefaciens\n\n      119. GN Myroides odoratimimus\n\n      120. GN Myroides odoratus\n\n      121. GN Oligella ureolytica\n\n      122. GN Oligella urethralis\n\n      123. AA Parabacteroides distasonis\n\n      124. GP Pediococcus pentosaceus\n\n      125. AA Peptoniphilus harei\n\n      126. AA Peptostreptococcus anaerobius\n\n      127. GN Plesiomonas shigelloides\n\n      128. AA Porphyromonas gingivalis\n\n      129. AA Porphyromonas somerae\n\n      130. AA Prevotella bivia\n\n      131. AA Prevotella buccae\n\n      132. AA Prevotella denticola\n\n      133. AA Prevotella intermedia\n\n      134. AA Prevotella loescheii\n\n      135. AA Prevotella melaninogenica\n\n      136. AA Propionibacterium acnes\n\n      137. GN Pseudomonas oryzihabitans\n\n      138. GN Pseudomonas stutzeri\n\n      139. GN Rhizobium radiobacter\n\n      140. GP Rothia aeria\n\n      141. GP Rothia dentocariosa\n\n      142. GP Rothia mucilaginosa\n\n      143. GN Serratia plymuthica\n\n      144. GN Serratia rubidaea\n\n      145. GP Staphylococcus aureus\n\n      146. GP Staphylococcus auricularis\n\n      147. GP Staphylococcus capitis\n\n      148. GP Staphylococcus caprae\n\n      149. GP Staphylococcus carnosus\n\n      150. GP Staphylococcus cohnii\n\n      151. GP Staphylococcus epidermidis\n\n      152. GP Staphylococcus equorum\n\n      153. GP Staphylococcus felis\n\n      154. GP Staphylococcus haemolyticus\n\n      155. GP Staphylococcus hominis\n\n      156. GP Staphylococcus lugdunensis\n\n      157. GP Staphylococcus lutrae\n\n      158. GP Staphylococcus pasteuri\n\n      159. GP Staphylococcus pettenkoferi\n\n      160. GP Staphylococcus pseudintermedius\n\n      161. GP Staphylococcus saccharolyticus\n\n      162. GP Staphylococcus saprophyticus\n\n      163. GP Staphylococcus schleiferi\n\n      164. GP Staphylococcus simulans\n\n      165. GP Staphylococcus vitulinus\n\n      166. GP Staphylococcus warneri\n\n      167. GP Streptococcus agalactiae\n\n      168. GP Streptococcus anginosus\n\n      169. GP Streptococcus constellatus\n\n      170. GP Streptococcus dysgalactiae\n\n      171. GP Streptococcus gallolyticus\n\n      172. GP Streptococcus gordonii\n\n      173. GP Streptococcus infantis\n\n      174. GP Streptococcus intermedius\n\n      175. GP Streptococcus lutetiensis\n\n      176. GP Streptococcus mitis\n\n      177. GP Streptococcus mutans\n\n      178. GP Streptococcus oralis\n\n      179. GP Streptococcus pneumoniae\n\n      180. GP Streptococcus pyogenes\n\n      181. GP Streptococcus salivarius_ssp_salivarius\n\n      182. GP Streptococcus salivarius_ssp_thermophilus\n\n      183. AA Sutterella wadsworthensis\n\n      184. YE Trichosporon asahii\n\n      185. GN Vibrio parahaemolyticus\n\n      186. GN Vibrio vulnificus\n\n      AA = Anaerobes GN = Gram neg. Aerobes GP = Gram pos. Aerobes MA = Microaerophilics YE =\n      Yeasts"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        -Patients with infections from certain yeasts, Gram positive or Gram negative bacteria\n        (see Detailed Description)\n\n        Exclusion Criteria:\n\n        -Patients without infections from the quoted microorganisms (see Detailed Description)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with infections from certain yeasts, Gram positive or certain Gram negative\n        bacteria (see Further Information / Target microorganisms of study)"
            }
        }, 
        "enrollment": {
            "#text": "3000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 25, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02098226", 
            "org_study_id": "BDAL-2013-001"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 26, 2014", 
        "number_of_groups": "1", 
        "official_title": "Method Comparison Protocol: MALDI Biotyper-Clinical Applications (MBT-CA) Phase 2", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Substantial equivalence of MBT-CA with sequencing concerning determination of the respective bacteria and yeasts", 
            "safety_issue": "No", 
            "time_frame": "half a year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02098226"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Bruker Daltonics", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bruker Daltonics", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}